Tumor-associated macrophage subtypes on cancer immunity along with prognostic analysis and SPP1-mediated interactions between tumor cells and macrophages

PLoS Genet. 2024 Apr 22;20(4):e1011235. doi: 10.1371/journal.pgen.1011235. eCollection 2024 Apr.

Abstract

Tumor-associated macrophages (TAM) subtypes have been shown to impact cancer prognosis and resistance to immunotherapy. However, there is still a lack of systematic investigation into their molecular characteristics and clinical relevance in different cancer types. Single-cell RNA sequencing data from three different tumor types were used to cluster and type macrophages. Functional analysis and communication of TAM subpopulations were performed by Gene Ontology-Biological Process and CellChat respectively. Differential expression of characteristic genes in subpopulations was calculated using zscore as well as edgeR and Wilcoxon rank sum tests, and subsequently gene enrichment analysis of characteristic genes and anti-PD-1 resistance was performed by the REACTOME database. We revealed the heterogeneity of TAM, and identified eleven subtypes and their impact on prognosis. These subtypes expressed different molecular functions respectively, such as being involved in T cell activation, apoptosis and differentiation, or regulating viral bioprocesses or responses to viruses. The SPP1 pathway was identified as a critical mediator of communication between TAM subpopulations, as well as between TAM and epithelial cells. Macrophages with high expression of SPP1 resulted in poorer survival. By in vitro study, we showed SPP1 mediated the interactions between TAM clusters and between TAM and tumor cells. SPP1 promoted the tumor-promoting ability of TAM, and increased PDL1 expression and stemness of tumor cells. Inhibition of SPP1 attenuated N-cadherin and β-catenin expression and the activation of AKT and STAT3 pathway in tumor cells. Additionally, we found that several subpopulations could decrease the sensitivity of anti-PD-1 therapy in melanoma. SPP1 signal was a critical pathway of communication between macrophage subtypes. Some specific macrophage subtypes were associated with immunotherapy resistance and prognosis in some cancer types.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Communication / immunology
  • Cell Line, Tumor
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Macrophages / immunology
  • Macrophages / metabolism
  • Neoplasms* / genetics
  • Neoplasms* / immunology
  • Osteopontin* / genetics
  • Osteopontin* / metabolism
  • Prognosis
  • STAT3 Transcription Factor / genetics
  • STAT3 Transcription Factor / metabolism
  • Signal Transduction
  • Single-Cell Analysis
  • Tumor-Associated Macrophages* / immunology
  • Tumor-Associated Macrophages* / metabolism
  • beta Catenin / genetics
  • beta Catenin / metabolism

Substances

  • Osteopontin
  • SPP1 protein, human
  • STAT3 Transcription Factor
  • beta Catenin
  • STAT3 protein, human
  • CTNNB1 protein, human

Grants and funding

This project was supported by the National Natural Science Foundation of China 81972479 (to ZZZ), U2004118 (to YBC), 82072899 (to HSL), 81974004 (to LLL), the Natural Science Foundation of Guangdong Province 2024A1515010310 (to ZZZ), the Natural Science Foundation of Henan Province (202300410359) (to YBC) and the Medical Program of Henan Province (SBGJ2020002081) (to YBC). Supported by Guangzhou High-level Clinical Key Specialty Construction Project, Guangzhou Medical University Clinical Key Specialty Construction Project (202005, China) (to HSL), and Guangdong University Innovation Project (No. 2021KTSCX026, China) (to ZZZ). Supported by the Research and Innovation Team Fund of the First Affiliated Hospital of Zhengzhou University (QNCXTD2023019) (to YBC). Supported by the Open Fund of State Key Laboratory of Oncology in South China (to ZZZ). The funders had no role in study design, data collection and analysis, decision to publish, or writing the manuscript.